MX358176B - El uso de intensificadores, posiblemente asociados con riboflavina, asi como composiciones oftalmicas correspondientes para reticulacion de la cornea, en el tratamiento de queratocono o de otras alteraciones ectasicas de la córnea. - Google Patents
El uso de intensificadores, posiblemente asociados con riboflavina, asi como composiciones oftalmicas correspondientes para reticulacion de la cornea, en el tratamiento de queratocono o de otras alteraciones ectasicas de la córnea.Info
- Publication number
- MX358176B MX358176B MX2013013707A MX2013013707A MX358176B MX 358176 B MX358176 B MX 358176B MX 2013013707 A MX2013013707 A MX 2013013707A MX 2013013707 A MX2013013707 A MX 2013013707A MX 358176 B MX358176 B MX 358176B
- Authority
- MX
- Mexico
- Prior art keywords
- corneal
- keratoconus
- enhancers
- linking
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describe aquí el uso de intensificadores posiblemente con riboflavina, así como las composiciones correspondientes para el tratamiento de queratocono u otras alteraciones ectásicas de la córnea, por medio del método de reticulación de la córnea.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM2008A000472A IT1393402B1 (it) | 2008-08-28 | 2008-08-28 | Uso di enhancer eventualmente con riboflavina, nonche' relative composizioni oftalmiche per cross-linking corneale del cheratocono o di altre patologie ectasiche corneali |
PCT/IT2009/000392 WO2010023705A1 (en) | 2008-08-28 | 2009-08-27 | Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
MX358176B true MX358176B (es) | 2018-08-08 |
Family
ID=40679354
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011002234A MX2011002234A (es) | 2008-08-28 | 2009-08-27 | El uso de intensificadores, posiblemente asociados con riboflavina, asi como composiciones oftalmicas correspondientes para la reticulacion de la cornea, en el tratamiento de queratocono o de otras alteraciones ectasicas de la cornea. |
MX2013013707A MX358176B (es) | 2008-08-28 | 2009-08-27 | El uso de intensificadores, posiblemente asociados con riboflavina, asi como composiciones oftalmicas correspondientes para reticulacion de la cornea, en el tratamiento de queratocono o de otras alteraciones ectasicas de la córnea. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011002234A MX2011002234A (es) | 2008-08-28 | 2009-08-27 | El uso de intensificadores, posiblemente asociados con riboflavina, asi como composiciones oftalmicas correspondientes para la reticulacion de la cornea, en el tratamiento de queratocono o de otras alteraciones ectasicas de la cornea. |
Country Status (18)
Country | Link |
---|---|
US (1) | US20110152219A1 (es) |
EP (1) | EP2323642B1 (es) |
JP (1) | JP2012500844A (es) |
KR (1) | KR20110046567A (es) |
CN (1) | CN102164592B (es) |
AU (1) | AU2009286285B2 (es) |
BR (1) | BRPI0910368B8 (es) |
CL (1) | CL2011000378A1 (es) |
DK (1) | DK2323642T3 (es) |
EA (2) | EA022055B1 (es) |
ES (1) | ES2460578T3 (es) |
IL (1) | IL211448A (es) |
IT (1) | IT1393402B1 (es) |
MX (2) | MX2011002234A (es) |
PE (1) | PE20110287A1 (es) |
PL (1) | PL2323642T3 (es) |
PT (1) | PT2323642E (es) |
WO (1) | WO2010023705A1 (es) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009073213A1 (en) | 2007-12-05 | 2009-06-11 | Avedro, Inc. | Eye therapy system |
WO2010039854A1 (en) | 2008-09-30 | 2010-04-08 | Neal Marshall | Eye therapy system |
US9707126B2 (en) | 2009-10-21 | 2017-07-18 | Avedro, Inc. | Systems and methods for corneal cross-linking with pulsed light |
WO2011050164A1 (en) | 2009-10-21 | 2011-04-28 | Avedro, Inc. | Eye therapy |
JP6377906B2 (ja) | 2010-03-19 | 2018-08-22 | アヴェドロ・インコーポレーテッドAvedro,Inc. | 眼治療を適用およびモニターするためのシステム |
US20120289886A1 (en) * | 2010-04-13 | 2012-11-15 | Avedro, Inc. | Controlled application of cross-linking agent |
US20110280763A1 (en) * | 2010-05-17 | 2011-11-17 | Abbott Medical Optics Inc. | Light-activated disinfection system |
IT1400982B1 (it) | 2010-07-05 | 2013-07-05 | Pinelli | Collirio osmotico trans-epiteliale per la cura del cheratocono. |
US9622911B2 (en) | 2010-09-30 | 2017-04-18 | Cxl Ophthalmics, Llc | Ophthalmic treatment device, system, and method of use |
EA022306B1 (ru) | 2011-01-12 | 2015-12-30 | Соофт Италия Спа | Устройство и способ подачи рибофлавина в роговицу путем ионофореза для лечения кератоконуса |
MX2013008042A (es) | 2011-01-12 | 2013-09-16 | Sooft Italia Spa | Suministro a la cornea de agentes de reticulacion mediante iontoforesis, para el tratamiento del queratocono y composiciones oftalmicas relacionadas. |
US9044308B2 (en) | 2011-05-24 | 2015-06-02 | Avedro, Inc. | Systems and methods for reshaping an eye feature |
WO2012167260A2 (en) | 2011-06-02 | 2012-12-06 | Avedro, Inc. | Systems and methods for monitoring time based photo active agent delivery or photo active marker presence |
ITRM20110560A1 (it) * | 2011-10-25 | 2013-04-26 | Sooft Italia Spa | Migliorata composizione di cross-linking per il trattamento del cheratocono mediante iontoforesi |
RU2481809C1 (ru) * | 2011-12-21 | 2013-05-20 | Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" | Способ лечения кератэктазии после лазик |
EP2830637A4 (en) | 2012-03-29 | 2016-03-16 | Cxl Ophthalmics Llc | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING DISEASES RELATED TO OXIDATIVE STRESS |
WO2013148896A1 (en) * | 2012-03-29 | 2013-10-03 | Cxl Ophthalmics, Llc | Ocular treatment solutions, delivery devices and delivery augmentation methods |
WO2013148895A1 (en) | 2012-03-29 | 2013-10-03 | Cxl Ophthalmics, Llc | Ocular cross-linking system and method for sealing corneal wounds |
RU2487691C1 (ru) * | 2012-04-12 | 2013-07-20 | Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации | Способ лечения кератоконуса |
WO2014114359A1 (en) * | 2013-01-28 | 2014-07-31 | Wavelight Gmbh | Apparatus for corneal crosslinking |
EP3858356A3 (en) * | 2013-05-19 | 2021-12-01 | Avedro, Inc. | Systems, methods, and compositions for cross-linking |
WO2014205145A1 (en) | 2013-06-18 | 2014-12-24 | Avedro, Inc. | Systems and methods for determining biomechanical properties of the eye for applying treatment |
US9498114B2 (en) | 2013-06-18 | 2016-11-22 | Avedro, Inc. | Systems and methods for determining biomechanical properties of the eye for applying treatment |
RU2542799C1 (ru) * | 2013-10-29 | 2015-02-27 | Игорь Борисович Медведев | Способ лечения кератоконуса роговицы |
US9931199B2 (en) * | 2014-05-05 | 2018-04-03 | Roberto Gustavo ALBERTAZZI | Methods and apparatus for treating keratoconus |
US10195081B1 (en) | 2014-05-12 | 2019-02-05 | Gholam A. Peyman | Method of prevention of capsular opacification and fibrosis after cataract extraction and/or prevention of fibrosis around a shunt or stent after glaucoma surgery |
US10278920B1 (en) | 2014-05-12 | 2019-05-07 | Gholam A. Peyman | Drug delivery implant and a method using the same |
US10314690B1 (en) | 2014-05-12 | 2019-06-11 | Gholam A. Peyman | Method of corneal transplantation or corneal inlay implantation with cross-linking |
US11565023B2 (en) | 2014-05-12 | 2023-01-31 | Gholam A. Peyman | Method of corneal transplantation or corneal inlay implantation with cross-linking |
US11666777B2 (en) | 2014-05-12 | 2023-06-06 | Gholam A. Peyman | Photodynamic therapy technique for preventing damage to the fovea of the eye or another body portion of a patient |
US11648261B2 (en) | 2014-05-12 | 2023-05-16 | Gholam A. Peyman | Method of treating, reducing, or alleviating a medical condition in a patient |
US9427355B1 (en) * | 2014-05-12 | 2016-08-30 | Gholam A. Peyman | Corneal transplantation with a cross-linked cornea |
US10881503B2 (en) | 2014-05-12 | 2021-01-05 | Gholam A. Peyman | Method of corneal transplantation or corneal inlay implantation with cross-linking |
US11045352B2 (en) | 2014-05-12 | 2021-06-29 | Gholam A. Peyman | Methods for treatment of dry eye and other acute or chronic inflammatory processes |
US9744029B1 (en) | 2014-05-12 | 2017-08-29 | Gholam A. Peyman | Method of preventing capsular opacification and fibrosis utilizing an accommodative intraocular lens implant |
US10709546B2 (en) | 2014-05-12 | 2020-07-14 | Gholam A. Peyman | Intracorneal lens implantation with a cross-linked cornea |
US10583221B2 (en) | 2014-05-12 | 2020-03-10 | Gholam A. Peyman | Method of corneal transplantation or corneal inlay implantation with cross-linking |
US9937033B1 (en) | 2014-05-12 | 2018-04-10 | Gholam A. Peyman | Corneal lenslet implantation with a cross-linked cornea |
US11338059B2 (en) | 2014-05-12 | 2022-05-24 | Gholam A. Peyman | Method of corneal and scleral inlay crosslinking and preservation |
US10206569B1 (en) | 2014-05-12 | 2019-02-19 | Gholam A. Peyman | Corneal intraocular pressure sensor and a surgical method using the same |
US10925889B2 (en) | 2014-05-12 | 2021-02-23 | Gholam A. Peyman | Method of treating, reducing, or alleviating a medical condition in a patient |
US11259914B2 (en) | 2014-05-12 | 2022-03-01 | Gholam A. Peyman | Molding or 3-D printing of a synthetic refractive corneal lenslet |
CN107205845B (zh) | 2014-10-27 | 2020-03-31 | 艾维德洛公司 | 用于眼的交联治疗的系统和方法 |
US10114205B2 (en) | 2014-11-13 | 2018-10-30 | Avedro, Inc. | Multipass virtually imaged phased array etalon |
EP3827792A1 (en) | 2015-04-24 | 2021-06-02 | Avedro, Inc. | Systems and methods for photoactivating a photosensitizer applied to an eye |
PT3288588T (pt) | 2015-04-29 | 2018-11-13 | Sooft Italia Spa | Agentes de reticulação melhorados de fibras de colagénio para uso no tratamento da ectasia corneana |
WO2016191342A1 (en) | 2015-05-22 | 2016-12-01 | Avedro, Inc. | Systems and methods for monitoring cross-linking activity for corneal treatments |
CN108025011A (zh) * | 2015-07-21 | 2018-05-11 | 艾维德洛公司 | 用光敏剂治疗眼睛的系统和方法 |
CN105256059B (zh) * | 2015-11-20 | 2019-01-18 | 山东省眼科研究所 | Tuba3d基因在制备圆锥角膜诊断制品中的应用 |
ITUB20160237A1 (it) | 2016-01-26 | 2017-07-26 | Vision Engineering Italy Soc A Responsabilita Limitata | Apparato di controllo del dosaggio di un agente cromoforo in un tessuto corneale e procedimento per dosare un agente cromoforo in un tessuto corneale |
EP3442481B1 (en) | 2016-04-13 | 2023-06-28 | Avedro, Inc. | Systems for delivering drugs to an eye |
US20180236077A1 (en) * | 2017-02-21 | 2018-08-23 | Avedro, Inc. | Formulations for eye treatments |
AU2019231257A1 (en) | 2018-03-05 | 2020-10-15 | Avedro, Inc. | System for eye tracking during eye treatment |
US11766356B2 (en) | 2018-03-08 | 2023-09-26 | Avedro, Inc. | Micro-devices for treatment of an eye |
US12016794B2 (en) | 2018-10-09 | 2024-06-25 | Avedro, Inc. | Photoactivation systems and methods for corneal cross-linking treatments |
US11707518B2 (en) | 2019-04-28 | 2023-07-25 | Gholam A. Peyman | Method of treating, reducing, or alleviating a medical condition in a patient |
WO2021026405A1 (en) | 2019-08-06 | 2021-02-11 | Avedro, Inc. | Photoactivation systems and methods for corneal cross-linking treatments |
CN110314034B (zh) * | 2019-08-08 | 2021-12-03 | 南京市第一医院 | 一种可实现个性治疗的角膜交联装置 |
US11458220B2 (en) | 2020-11-12 | 2022-10-04 | Singletto Inc. | Microbial disinfection for personal protection equipment |
CN115177729B (zh) * | 2022-08-03 | 2023-09-26 | 山东第一医科大学附属眼科研究所(山东省眼科研究所、山东第一医科大学附属青岛眼科医院) | 肾上腺素受体激动剂在制备圆锥角膜交联促渗剂中的应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050002867A1 (en) * | 1997-10-01 | 2005-01-06 | Novadel Pharma Inc. | Buccal, polar and non-polar sprays containing propofol |
EP1061873B1 (en) * | 1998-03-09 | 2005-11-02 | Ista Pharmaceuticals, Inc | Use of glyceraldehyde as corneal hardening agents |
US6174524B1 (en) | 1999-03-26 | 2001-01-16 | Alcon Laboratories, Inc. | Gelling ophthalmic compositions containing xanthan gum |
AU2001249984B2 (en) * | 2000-02-11 | 2005-05-26 | The General Hospital Corporation | Photochemical tissue bonding |
JP5583310B2 (ja) * | 2002-12-20 | 2014-09-03 | チャクシュ・リサーチ・インコーポレーテッド | 眼球の症状の予防及び治療のための眼科用製剤 |
ITRM20050443A1 (it) * | 2005-08-12 | 2007-02-13 | Opocrin Spa | Preparati oftalmici a base di polisaccaridi mucoadesivi con capacita' riepitelizzante della cornea. |
US20120203161A1 (en) * | 2009-08-12 | 2012-08-09 | Seros Medical, Llc | Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method of use |
-
2008
- 2008-08-28 IT ITRM2008A000472A patent/IT1393402B1/it active
-
2009
- 2009-08-27 EA EA201100393A patent/EA022055B1/ru not_active IP Right Cessation
- 2009-08-27 WO PCT/IT2009/000392 patent/WO2010023705A1/en active Application Filing
- 2009-08-27 CN CN200980138188.3A patent/CN102164592B/zh active Active
- 2009-08-27 EP EP09748494.3A patent/EP2323642B1/en active Active
- 2009-08-27 MX MX2011002234A patent/MX2011002234A/es active IP Right Grant
- 2009-08-27 AU AU2009286285A patent/AU2009286285B2/en active Active
- 2009-08-27 BR BRPI0910368A patent/BRPI0910368B8/pt active IP Right Grant
- 2009-08-27 PL PL09748494T patent/PL2323642T3/pl unknown
- 2009-08-27 DK DK09748494.3T patent/DK2323642T3/da active
- 2009-08-27 JP JP2011524534A patent/JP2012500844A/ja active Pending
- 2009-08-27 KR KR1020117006855A patent/KR20110046567A/ko not_active Application Discontinuation
- 2009-08-27 ES ES09748494.3T patent/ES2460578T3/es active Active
- 2009-08-27 PE PE2011000192A patent/PE20110287A1/es not_active Application Discontinuation
- 2009-08-27 MX MX2013013707A patent/MX358176B/es unknown
- 2009-08-27 PT PT97484943T patent/PT2323642E/pt unknown
- 2009-08-27 EA EA201300272A patent/EA023607B1/ru not_active IP Right Cessation
-
2011
- 2011-02-22 CL CL2011000378A patent/CL2011000378A1/es unknown
- 2011-02-27 IL IL211448A patent/IL211448A/en active IP Right Grant
- 2011-02-28 US US13/036,492 patent/US20110152219A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EA022055B1 (ru) | 2015-10-30 |
WO2010023705A1 (en) | 2010-03-04 |
EP2323642B1 (en) | 2014-02-19 |
AU2009286285A1 (en) | 2010-03-04 |
IL211448A (en) | 2016-05-31 |
MX2011002234A (es) | 2011-04-05 |
EP2323642A1 (en) | 2011-05-25 |
PL2323642T3 (pl) | 2014-07-31 |
CN102164592B (zh) | 2015-09-23 |
CL2011000378A1 (es) | 2011-06-10 |
EA023607B1 (ru) | 2016-06-30 |
JP2012500844A (ja) | 2012-01-12 |
ITRM20080472A1 (it) | 2010-02-28 |
CN102164592A (zh) | 2011-08-24 |
EA201100393A1 (ru) | 2011-10-31 |
PT2323642E (pt) | 2014-05-15 |
US20110152219A1 (en) | 2011-06-23 |
AU2009286285B2 (en) | 2015-03-26 |
IL211448A0 (en) | 2011-05-31 |
PE20110287A1 (es) | 2011-05-15 |
IT1393402B1 (it) | 2012-04-20 |
BRPI0910368A2 (pt) | 2015-10-13 |
EA201300272A1 (ru) | 2013-07-30 |
DK2323642T3 (da) | 2014-05-05 |
BRPI0910368B8 (pt) | 2021-05-25 |
ES2460578T3 (es) | 2014-05-13 |
KR20110046567A (ko) | 2011-05-04 |
BRPI0910368B1 (pt) | 2020-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX358176B (es) | El uso de intensificadores, posiblemente asociados con riboflavina, asi como composiciones oftalmicas correspondientes para reticulacion de la cornea, en el tratamiento de queratocono o de otras alteraciones ectasicas de la córnea. | |
MY175318A (en) | Androgen composition for treating an opthalmic condition | |
MX355606B (es) | Método in vitro para determinar el potencial miope de un paciente. | |
MX2015012502A (es) | Inhibidores de proteina cinasa dependiente de adn. | |
MX370853B (es) | Formulaciones que contienen dapagliflozina amorfa. | |
MY159463A (en) | Method and composition for treating ocular hypertension and glaucoma | |
MY169328A (en) | Compositions for the treatment of dry eye | |
MX359854B (es) | Anticuerpos anti-cxcr3. | |
CR20110029A (es) | Moduladores de diamino-piridina, pirimidina, y piridazina del receptor h4 de histamina | |
MY149705A (en) | Pyridino-pyridinone derivatives, preparation therof, and therapeutic use thereof | |
UY32125A (es) | Compuestos novedosos como ligandos de receptores de canabinoides | |
MX362271B (es) | Nueva forma cristalina de ciclosporina a, metodos de preparacion y metodos para su uso. | |
NZ704178A (en) | Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions | |
TR201909158T4 (tr) | siRNA ve göz rahatsızlıklarının tedavisi ve/veya önlenmesine yönelik yöntemler ve bileşimlerde kullanımları. | |
MX2011008645A (es) | Inhibidores de tetrahidrotiazolopiridina de fosfatidilinositol 3 cinasa. | |
EA201492152A1 (ru) | Налмефен для уменьшения потребления алкоголя у конкретных целевых популяций | |
UA114486C2 (uk) | Застосування 4-амінопіридину у лікуванні пов'язаної з інсультом сенсорно-рухової недостатності | |
UA103197C2 (uk) | Застосування ніфуртимоксу для лікування хвороб, спричинених трихомонадами | |
EP2596787A4 (en) | NEW USE OF HESPERETIN | |
EA201490938A1 (ru) | Производные спиротиенопиранпиперидина в качестве антагонистов рецептора orl-1 для применения для лечения алкогольной зависимости и злоупотребления алкоголем | |
MX356814B (es) | Métodos y composiciones para neuroprotección. | |
BR112012010795A2 (pt) | Formulações oftálmicas contendo gama lactams substituídas e métodos para uso das mesmas | |
RS54013B1 (en) | HIGH-ELASTIC GELS IN OPTAMOLOGICAL SURGERY | |
EA201590782A1 (ru) | Оксирановые амины | |
AU2012312301A8 (en) | Compounds useful as inhibitors of choline kinase |